收藏切换
Current status of dosage forms and clinical use of conjugated estrogens
收藏切换
PDF
Si-yi WU1, 2, Jia-qi LI3, Jian DONG1, 2, Jun YE4, Mei-ying NING1, *
Acta Pharmaceutica Sinica | 2025, 60(4) : 949 - 958
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(4): 949-958
Reviews
Current status of dosage forms and clinical use of conjugated estrogens
Full
Si-yi WU1, 2, Jia-qi LI3, Jian DONG1, 2, Jun YE4, Mei-ying NING1, *
Affiliations
  • 1National Research Institute for Family Planning, Beijing 100081, China
  • 2Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100073, China
  • 3Henan University of Technology, Zhengzhou 450001, China
  • 4Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
Published: 2025-04-12 doi: 10.16438/j.0513-4870.2025-0015
Outline
收藏切换

Conjugated estrogens (CE) are widely used in menopausal hormone therapy (MHT) for the relief of menopause-related symptoms (e.g., vasodilatory symptoms, neuropsychiatric symptoms, genitourinary atrophy symptoms, etc.) and the prevention of postmenopausal osteoporosis. This article reviews the characteristics, pharmacological effects, and practical applications of different dosage forms of CE (tablets, creams, and injections) in clinical practice. It has been shown that tablet CE effectively regulates the body's temperature center through systemic treatment, reduces hot flashes and night sweats, promotes bone formation, and increases bone density. Cream CE is used for local treatment to improve the genitourinary syndrome of menopause (GSM). Injectable CE is used for the treatment of abnormal uterine bleeding caused by hormonal imbalance without organ pathology. CE administered intravenously is indicated only for short-term use to rapidly and temporarily increase estrogen levels. Additionally, CE plays an important role in metabolism by improving insulin clearance and sensitivity and potentially protecting the nervous and cardiovascular systems, demonstrating a wide range of therapeutic potential. This paper provides new ideas for the design and development of drug dosage forms by exploring the formulation and application of CE.

conjugated estrogen  /  hormone replacement therapy  /  dosage form  /  menopausal syndrome  /  genitourinary syndrome of menopause
Si-yi WU, Jia-qi LI, Jian DONG, Jun YE, Mei-ying NING. Current status of dosage forms and clinical use of conjugated estrogens[J]. Acta Pharmaceutica Sinica, 2025 , 60 (4) : 949 -958 . DOI: 10.16438/j.0513-4870.2025-0015
Year 2025 volume 60 Issue 4
PDF
197
87
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0015
  • Receive Date:2025-01-06
  • Online Date:2025-10-29
  • Published:2025-04-12
Article Data
Affiliations
History
  • Received:2025-01-06
  • Revised:2025-03-05
Funding
Affiliations
    1National Research Institute for Family Planning, Beijing 100081, China
    2Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100073, China
    3Henan University of Technology, Zhengzhou 450001, China
    4Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0015
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT